Liposomal Irinotecan + Oxaliplatin + Bevacizumab Versus Liposomal Irinotecan + 5-FU/LV

NCT06782685 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

138

Enrollment

OTHER

Sponsor class

Conditions

Advanced Pancreatic Cancer (Part 1)

Interventions

DRUG: Irinotecan liposoma
DRUG: oxaliplatin
DRUG: bevacizumab
DRUG: 5-FU
DRUG: LV
DRUG: Irinotecan Liposomal
DRUG: Irinotecan Liposomal
DRUG: Oxaliplatin

Sponsor

Dai, Guanghai